TP53 and lung carcinoma: In lung cancer, loss of p53 in mutant KRASG12D expressing cells leads to increased YAP nuclear localization and activity, suggesting that KRASG12D induced tumorigenesis is promoted by YAP in cells that have lost p53 tumor suppressor activity (Mao et al., 2017).